2000 Journal Article Treatment of peritoneal dialysis related peritonitisJohnson, D. W., Looke, D. and Sturtevant, J. M. (2000). Treatment of peritoneal dialysis related peritonitis. Australian and New Zealand Journal of Medicine, 30 (1), 97-97. doi: 10.1111/j.1445-5994.2000.tb01069.x |
2000 Journal Article Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patientsJohnson, David W., Kay, Troy D., Vesey, David A., Isbel, Nicole, Campbell, Scott B. and Hawley, Carmel M. (2000). Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients. Peritoneal Dialysis International, 20 (6), 766-771. |
2000 Journal Article A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patientsJohnson, D. W., Herzig, K., Purdie, D., Brown, A. M., Rigby, R. J., Nicol, D. L. and Hawley, C. M. (2000). A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation, 69 (5), 794-799. doi: 10.1097/00007890-200003150-00020 |
2000 Journal Article Vancomycin-resistant enterococci: seek and ye shall findJohnson, D. W., Bartley, P. B., Looke, D. F. M. and Nimmo, G. R. (2000). Vancomycin-resistant enterococci: seek and ye shall find. Medical Journal of Australia, 172 (3 January), 42-43. doi: 10.5694/j.1326-5377.2000.tb123892.x |
2000 Journal Article Severe irreversible proximal renal tubular acidosis and azotaemia secondary to cidofovirKay, T. D., Hogan, P., McLeod, S. E. and Johnson, D. W. (2000). Severe irreversible proximal renal tubular acidosis and azotaemia secondary to cidofovir. Nephron, 86 (3), 348-349. doi: 10.1159/000045794 |
2000 Journal Article Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulo-interstitial cellsJohnson, D. W., Saunders, H. J., Vesey, D. A., Qi, W., Field, M. J. and Pollock, C. A. (2000). Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulo-interstitial cells. Nephron, 86 (4), 473-481. doi: 10.1159/000045837 |
2000 Journal Article Is obesity a favorable prognostic factor in peritoneal dialysis patients?Johnson, David W., Herzig, Karen A., Purdie, David M., Chang, Wendy, Brown, Allison M., Rigby, Russell J., Campbell, Scott B., Nicol, David L. and Hawley, Carmel M. (2000). Is obesity a favorable prognostic factor in peritoneal dialysis patients?. Peritoneal dialysis international, 20 (6), 715-721. |
1999 Journal Article Clinical appearance of a post-transplant lymphoma following G-CSF therapy (Letters to the Editor)Johnson, D. W. and Herzig, K. A. (1999). Clinical appearance of a post-transplant lymphoma following G-CSF therapy (Letters to the Editor). Nephrology, Dialysis, Transplantation, 14 (7), 1806-1807. doi: 10.1093/ndt/14.7.1806 |
1999 Journal Article Sunshine, sweating and main d'accoucheurJohnson, David W., Parnham, Alan, Herzig, Karen and Wittmann, Johannes (1999). Sunshine, sweating and main d'accoucheur. The Lancet, 353 (9163), 1492-1492. doi: 10.1016/S0140-6736(99)02271-0 |
1999 Journal Article Marked elevation of blood cyclosporin and tacrolimus levels due to concurrent metronidazole therapy (Letters to the Editor)Johnson, David W. and Herzig, Karen (1999). Marked elevation of blood cyclosporin and tacrolimus levels due to concurrent metronidazole therapy (Letters to the Editor). Nephrology, Dialysis, Transplantation, 14 (2), 521-522. |
1999 Journal Article Cyclosporin Exerts a Direct Fibrogenic Effect on Human Tubulointerstitial Cells: Roles of Insulin-Like Growth Factor I, Transforming Growth Factor beta 1, and Platelet-Derived Growth Factor1Johnson, David W., Saunders, Heather J., Johnson, Fiona J., Huq, Syed O., Field, Michael J. and Pollock, Carol A. (1999). Cyclosporin Exerts a Direct Fibrogenic Effect on Human Tubulointerstitial Cells: Roles of Insulin-Like Growth Factor I, Transforming Growth Factor beta 1, and Platelet-Derived Growth Factor1. The Journal of Pharmacology and Experimental Therapeutics, 289 (1), 535-542. |
1999 Journal Article Fibrogenic Effects of Cyclosporin A on the Tubulointerstitium: Role of Cytokines and Growth FactorsJohnson, David W., Saunders, Heather J., Johnson, Fiona J., Huq, Syed O., Field, Michael J. and Pollock, Carol A. (1999). Fibrogenic Effects of Cyclosporin A on the Tubulointerstitium: Role of Cytokines and Growth Factors. Experimental Nephrology, 7 (5-6), 470-478. doi: 10.1159/000020626 |
1999 Journal Article Serum leptin correlates with fat mass but not dietary energy intake in continuous ambulatory peritoneal dialysis patientsParry, R. G., Johnson, D. W., Carey, D., Hibbins, M., Chang, W., Rigby, R. and Purdie, D. M. (1999). Serum leptin correlates with fat mass but not dietary energy intake in continuous ambulatory peritoneal dialysis patients. Peritoneal Dialysis International, 18 (6), 569-575. doi: 10.1177/089686089801800603 |
1996 Journal Article Monitoring of extracellular and total body water during haemodialysis using multifrequency bio-electrical impedance analysisJohnson, DW, Thomas, BJ, Fleming, SJ, Westhuyzen, J, Moran, D and Ward, LC (1996). Monitoring of extracellular and total body water during haemodialysis using multifrequency bio-electrical impedance analysis. Kidney & Blood Pressure Research, 19 (2), 94-99. doi: 10.1159/000174050 |
1996 Journal Article Non-invasive, optical measurement of absolute blood volume in hemodialysis patientsJohnson, David W., McMahon, Miriam, Campbell, Scott, Wilkinson, James, Kime, Neil, Shannon, Gerald and Fleming, Simon J. (1996). Non-invasive, optical measurement of absolute blood volume in hemodialysis patients. Kidney International, 49 (1), 255-260. doi: 10.1038/ki.1996.36 |
1996 Journal Article The role of dexa bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patientsJohnson, D. W., McIntyre, H. D., Brown, A. and Freeman, J. (1996). The role of dexa bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients. Peritoneal Dialysis International, 16 (1), 34-40. |
1996 Journal Article A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patientsJohnson, D. W., Rigby, R. J., McIntyre, H. D., Brown, A. and Freeman, J. (1996). A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients. Nephrology Dialysis Transplantation, 11 (1), 88-93. |
1995 Journal Article Moraxella nonliquefaciens septic arthritis in a patient undergoing hemodialysisJohnson, DW, Lum, G, Nimmo, G and Hawley, CM (1995). Moraxella nonliquefaciens septic arthritis in a patient undergoing hemodialysis. Clinical Infectious Diseases, 21 (4), 1039-1040. doi: 10.1093/clinids/21.4.1039 |
1993 Journal Article Cervical Self-Manipulation and StrokeJohnson, David W., Whiting, Gerald and Pender, Michael P. (1993). Cervical Self-Manipulation and Stroke. Medical Journal of Australia, 158 (4), 290. |